ARMO BioSciences Inc. (Nasdaq: ARMO) will be acquired by Eli Lilly (NYSE: LLY) for a premium of approximately $1.6 billion in cash. Shares of ARMO BioSciences rocketed $19.98 to close at $49.80 while Eli Lilly stock climbed $1.59 to close at $80.86.